|Mean Score Change (pre-op to 6 months)|
* This study utilized a non-Stryker VeraSense variant in reaching its conclusions. Outcomes may vary when using a Stryker variant.
The VeraSense trial, which replaces the standard Triathlon tibial insert trial, can be used during the trialing and final implantation stages of TKA. It utilizes proprietary sensor technology to provide you the following real-time data:
The VeraSense software displays this information on a tablet – the LinkStation MINI – via Bluetooth communication, allowing you to intraoperatively view and capture the compartmental loads at multiple degrees of flexion and assess joint kinetics throughout a range of motion.
**For reference only
Dr. Martin Roche and Dr. Kevin Wang discuss their experiences and outcomes using VeraSense for Triathlon, including details on how they critically analyze intraoperative VeraSense load data to address imbalances in commonly encountered balancing scenarios.
A surgeon must always rely on his or her own professional clinical judgment when deciding whether to use a particular product when treating a particular patient. Stryker does not dispense medical advice and recommends that surgeons be trained in the use of any particular product before using it in surgery. The information presented is intended to demonstrate the breadth of Stryker’s product offerings. A surgeon must always refer to the package insert, product label and/or instructions for use before using any of Stryker’s products.
Products may not be available in all markets because product availability is subject to the regulatory and/or medical practices in individual markets. Please contact your sales representative if you have questions about the availability of products in your area. Stryker Corporation or its divisions or other corporate affiliated entities own, use or have applied for the following trademarks or service marks: Stryker, Triathlon, VeraSense. All other trademarks are trademarks of their respective owners or holders.